G2GBIO지투지바이오
456160 · KOSDAQ · ₩456160 · 지투지바이오
₩37,900▼ ₩1,250 (3.19%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | |
|---|---|---|
| Revenue | ₩423M | ₩769M |
| Cost of sales | ₩457M | ₩579M |
| Gross profit | −₩33M | ₩190M |
| Operating income | −₩12B | −₩11B |
| Net income | −₩12B | −₩83B |
| Net income to shareholders | −₩12B | −₩83B |
Balance sheet
| 2025 | 2024 | |
|---|---|---|
| Total assets | ₩68B | ₩25B |
| Current assets | ₩53B | ₩11B |
| Cash and equivalents | ₩8B | ₩10B |
| Total liabilities | ₩9.4B | ₩145B |
| Current liabilities | ₩7.3B | ₩142B |
| Borrowings | ₩2.2B | ₩11B |
| Total equity | ₩58B | −₩120B |
| Shareholders' equity | ₩58B | −₩120B |
Cash flow
| 2025 | 2024 | |
|---|---|---|
| Cash from operations | −₩14B | −₩8B |
| Capital spending | ₩312M | ₩577M |
| Free cash flow | −₩14B | −₩8.5B |
Consolidated where available. Amounts in won.
Also known as: G2GBIO / 지투지바이오 / 456160 / KRX:456160
Source: KRX statistical information